Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Terminated × Urothelial Cancer × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 112 Neoplasms 89 Breast Neoplasms 87 Multiple Myeloma 73 Leukemia, Myeloid, Acute 73 Melanoma 72 Neoplasm Metastasis 69 Recurrence 62 Ovarian Neoplasms 58 Colorectal Neoplasms 52 Prostatic Neoplasms 50 Lymphoma 49 Leukemia 47 Lymphoma, Non-Hodgkin 45 Lung Neoplasms 42 Pancreatic Neoplasms 41 Leukemia, Lymphocytic, Chronic, B-Cell 37 Myelodysplastic Syndromes 35 Carcinoma, Renal Cell 33 Squamous Cell Carcinoma of Head and Neck 32 Precursor Cell Lymphoblastic Leukemia-Lymphoma 32 Carcinoma, Hepatocellular 30 Glioblastoma 29 Triple Negative Breast Neoplasms 26 Lymphoma, Large B-Cell, Diffuse 25 Brain Neoplasms 25 Stomach Neoplasms 24 Small Cell Lung Carcinoma 23 Lymphoma, Follicular 21 Urinary Bladder Neoplasms 20

Interventions

durvalumab 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02891161 2024-11-27

DUART

Big Ten Cancer Research Consortium

Phase 1/2 Terminated

26 enrolled 20 charts

Urothelial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡